{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:16:18Z","timestamp":1761167778019,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ghir.2021.101419","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T01:21:24Z","timestamp":1627176084000},"page":"101419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Adult height and long-term outcomes after rhIGF-1 therapy in two patients with PAPP-A2 deficiency"],"prefix":"10.1016","volume":"60-61","author":[{"given":"\u00c1lvaro","family":"Mart\u00edn-Rivada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Mart\u00ednez D\u00edaz-Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Pozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel \u00c1ngel","family":"Martos-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Argente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2021.101419_bb0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.15252\/emmm.201506106","article-title":"Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability","volume":"8","author":"Dauber","year":"2016","journal-title":"EMBO. Mol. Med."},{"key":"10.1016\/j.ghir.2021.101419_bb0010","doi-asserted-by":"crossref","first-page":"21849","DOI":"10.1074\/jbc.M102191200","article-title":"Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase","volume":"276","author":"Overgaard","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2021.101419_bb0015","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.15252\/emmm.201707950","article-title":"One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology","volume":"9","author":"Argente","year":"2017","journal-title":"EMBO. Mol. Med."},{"key":"10.1016\/j.ghir.2021.101419_bb0020","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1210\/jc.2016-2751","article-title":"Treatment with recombinant human insulin-like growth Factor-1 improves growth in patients with PAPP-A2 deficiency","volume":"101","author":"Mu\u00f1oz-Calvo","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101419_bb0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000486336","article-title":"rhIGF-1 treatment increases bone mineral density and trabecular bone structure in children with PAPP-A2 deficiency","volume":"89","author":"Hawkins-Carranza","year":"2018","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2021.101419_bb0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2214\/ajr.145.3.611","article-title":"Sonographic measurements and appearance of normal kidneys in children","volume":"145","author":"Han","year":"1985","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ghir.2021.101419_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1148\/radiol.2311020963","article-title":"Spleen length in childhood with US: normal values based on age, sex, and somatometric parameters","volume":"231","author":"Megremis","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.ghir.2021.101419_bb0040","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children","volume":"95","author":"Zemel","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.ghir.2021.101419_bb0045"},{"key":"10.1016\/j.ghir.2021.101419_bb0050","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2006-1610","article-title":"GH insensitivity syndrome collaborative group, long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity","volume":"92","author":"Chernausek","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101419_bb0055","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1210\/jc.2007-2678","article-title":"Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels and hyperinsulinemia","volume":"93","author":"Heath","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2021.101419_bb0060","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1210\/en.2018-00755","article-title":"Low IGF-I bioavailability impairs growth and glucose metabolism in a mouse model of human PAPPA2 p.Ala1033Val mutation","volume":"160","author":"Fujimoto","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2021.101419_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ghir.2018.10.006","article-title":"Pappa2 deletion has sex- and age-specific effects on bone in mice","volume":"44","author":"Christians","year":"2019","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2021.101419_bb0070","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.3390\/ijms22084048","article-title":"Recombinant IGF-1 induces sex-specific changes in bone composition and remodeling in adult mice with Pappa2 deficiency","volume":"22","author":"Rubio","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ghir.2021.101419_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/cge.14030","article-title":"Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family","author":"Babiker","year":"2021","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ghir.2021.101419_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ghir.2018.04.001","article-title":"History and clinical implications of PAPP-A2 in human growth: when reflexions on idiopathic short stature lead to a specific and new diagnosis","volume":"40","author":"Argente","year":"2018","journal-title":"Growth Hormon. IGF Res."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:22Z","timestamp":1761087142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637421000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":16,"alternative-id":["S1096637421000423"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101419","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult height and long-term outcomes after rhIGF-1 therapy in two patients with PAPP-A2 deficiency","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101419"}}